Innovation – Page 29
-
NewsCRISPR-based drug candidate targets the microbiome
Scientists have engineered the first published CRISPR-based candidate for a drug - a combination of phages - that targets E. coli directly and leaves the microbiome intact.
-
NewsPattern-forming bacteria used with AI as sensors
Synthetic biologists have engineered bacterial swarm patterns to visibly record environment and use deep learning to decode patterns - applications could range from monitoring environmental pollution to building living materials.
-
NewsFaecal beads target serious intestinal infections
Researchers have developed small beads to be taken orally, which could radically improve the administration of faecal microbiota transplantation to treat Clostridioides difficile infection.
-
NewsBenchtop model lays bare secrets of gut microbiome
A benchtop model of the human gut (MiGut) has been developed to allow the interaction of drugs, nutrition, prebiotics, and live biotherapeutics with the gut microbiome to be studied in greater depth than ever before.
-
NewsAI-powered system diagnoses tomato leaf diseases
Researchers have developed an innovative deep learning architecture to accurately distinguish between different tomato leaf diseases.
-
NewsAlgorithm boosts Covid vaccine response 128-fold
Researchers have developed an AI algorithm that can rapidly design highly stable COVID-19 mRNA vaccine sequences that were previously unattainable, achieving a 128-fold increase in the vaccine’s antibody response.
-
NewsQuantum entanglement doubles microscope resolution
Using a ‘spooky’ phenomenon of quantum physics, Caltech researchers have discovered a way to double the resolution of light microscopes.
-
NewsDeep neural network spots pathogens in real time
Scientists have developed a deep neural network that can accurately identify biomarker signals in real time, on a system that is relatively cheap and portable for point-of-care applications.
-
NewsLiverpool begins first human trial of Zika vaccine
The first participant has received a dose of a new Zika virus vaccine being trialled by the University of Liverpool.
-
NewsCRISPR pioneers invent cutting-edge genome edit tool
The team that first discovered the CRISPR loci has now developed a new genome engineering tool that tackles some of the limitations of the most popular CRISPR-based tools.
-
NewsScientists build human lungs in dish to test drugs
Scientists have developed a step-by-step blueprint to create advanced human lung models in the lab, which they say will accelerate the discovery and development of new drugs and reduce reliance on animal testing.
-
NewsPhage delivers double whammy against biofilms
A novel bacteriophage isolated from sewage water not only kills its target bacteria in the Klebsiella oxytoca complex but was unexpectedly found to be capable of disrupting biofilms produced by these bacteria.
-
NewsAntimicrobial foam targets bugs or oil spills
A versatile new foam material could significantly reduce health care-related infections caused by implanted medical devices - or drastically improve cleanup efforts following environmental disasters like oil spills.
-
NewsmRNA ingredient produced by biocatalytic synthesis
The new and patented method for the production of the important mRNA vaccine component pseudouridine is more efficient, sustainable and cost-effective than the previously used chemical synthesis.
-
NewsNew device instantly detects pathogen nucleic acid
Researchers have developed a device for the on-site immediate detection of pathogen nucleic acid.
-
NewsFast and easy method detects antibiotic resistance
Scientists have developed a technique that obtains an antibiogram within 2-4 hours instead of the current 24 hours for the most common germs and one month for tuberculosis.
-
NewsInfectious SARS-CoV-2 isolated from hospital air samples
Scientists have succeeded in isolating infectious particles of the SARS-CoV-2 virus from air samples collected from hospital rooms of COVID-19 patients and kept frozen for more than a year, a new study shows.
-
NewsFirst rapid test for mpox can be tailored for other emerging diseases
The first rapid test for mpox has been developed - the selective molecular sensor can detect the virus within minutes, without the use of any high-end instrumental techniques.
-
NewsTiny biobattery with 100-year shelf life runs on bacteria
A tiny biobattery that could still work after 100 years has been developed by researchers.
-
NewsLabel-free droplet-based methods improve rapid screening and sorting of bacteria
Researchers have determined how to best screen bacteria by their observable characteristics using a microfluidic system and the autofluorescent properties of bacteria.